Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
The funds will be used to expand digital product offerings, grow their online customer base, and launch their flagship clinic in Bengaluru
Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise
The initiative will engage adolescents and youth of India in decisions about their reproductive health
Collaboration designed to bring reproductive health screening capabilities to hospitals and clinics across the country
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
Subscribe To Our Newsletter & Stay Updated
